Work

Abstract 826: Combination of CDK4/6 and CDK2/4/6 inhibitors with novel biguanides for pancreatic cancer treatment

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-826

Authors: Samantha A. Melendrez, Mario Morales Martinez, Eduardo Mauricio Gonzalez, Gang Deng, Timothy Donahue, Michael Jung, Jaydutt V. Vadgama, Richard Pietras, Diana C. Marquez-Garban

Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409690181

Cites:

Cited by:

Related to: 10